ex-vivo GBA stem cell-based gene therapy (AVROBIO)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameex-vivo GBA stem cell-based gene therapy (AVROBIO)
Drug Alias NameGBA-transduced hematopoietic stem cell-derived microglia (AVROBIO)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionBeta-glucocerebrosidase stimulants
TargetsBeta-glucocerebrosidase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAvrobio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvrobio Inc
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A